Sandra Thiemann
Ingelheim Am Rhein, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.
Journal: Diabetes, obesity & metabolism
Published: March 28, 2017
Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
Journal: Postgraduate medicine
Published: September 30, 2016
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.
Journal: Cardiovascular diabetology
Published: July 22, 2016
Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials.
Journal: Journal of diabetes and its complications
Published: April 28, 2016
Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: November 18, 2015
Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA® trial
Journal: Deutsche medizinische Wochenschrift (1946)
Published: June 18, 2015
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial.
Journal: Advances in therapy
Published: November 26, 2014
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.
Journal: Diabetes, obesity & metabolism
Published: July 22, 2014
Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.
Journal: Diabetes care
Published: September 25, 2013
Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
Journal: Clinical pharmacology in drug development
Published: July 23, 2013
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: August 06, 2012
Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.
Journal: Diabetes, obesity & metabolism
Published: July 20, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026